Skip to main content
OpenTrials

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

53 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Active, not recruiting

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

NCT06401044

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Amy Patel Jain MD Newport Beach, California, United States
  • Levenson Eye Associates Jacksonville, Florida, United States
  • Ilumina Medical Research Kissimmee, Florida, United States
View all 44 locations
View Trial Details
Active, not recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

NCT06248619

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
  • Advanced Quality Medical Research Orland Park, Illinois, United States
  • W Kellogg Eye Center Ann Arbor, Michigan, United States
  • Las Vegas Endocrinology Henderson, Nevada, United States
View all 38 locations
View Trial Details
Active, not recruiting

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

NCT06088979

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - Site 840-121 Tucson, Arizona, United States
  • Foothill Eye Institute - Site 840-116 Pasadena, California, United States
  • University of California Davis Eye Center - Site 840-119 Sacramento, California, United States
  • The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122 San Francisco, California, United States
View all 36 locations
View Trial Details
Completed

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT05276063

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations
  • Thrive Health Research Beverly Hills, California, United States
  • UC San Diego Health La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Byers Eye Institute - Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details
Completed

TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

NCT05002998

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • The Private Practice of Raymond Douglas, MD - Beverly Hills Beverly Hills, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado - Eye Center - PPDS Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

NCT06179875

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Eye Institute Los Angeles, California, United States
  • Advancing Research International, LLC Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 45 locations
View Trial Details
Completed

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

NCT05176639

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • University of Colorado - Department of Ophthalmology Aurora, California, United States
  • The Private Office of Raymond Douglas Beverly Hills, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • MACRO Trials, Inc. Los Angeles, California, United States
View all 53 locations
View Trial Details
Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • Advancing Research International, LLC Los Angeles, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
  • Cockerham Eye Consultants, PC San Diego, California, United States
View all 50 locations
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

NCT06021054

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • Amy Patel Jain, MD Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 57 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT06106828

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Plastics-Orbit-Neuro San Diego, California, United States
  • Connecticut Eye Consultants, P.C. Danbury, Connecticut, United States
  • University of Illinois Eye and Ear Infirmary Chicago, Illinois, United States
  • Scheie Eye Institute Philadelphia, Pennsylvania, United States
View all 41 locations
View Trial Details

Related conditions